ASH 2017: combination therapy for CLL highlights - 101793

Spotlight
Video

ASH 2017: combination therapy for CLL highlights

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: Numerous trials worldwide are now focusing on combination therapy for relapsed/refractory chronic lymphocytic leukemia (CLL). In this interview, Barbara Eichhorst, MD, of the University Hospital Cologne, Cologne, Germany, discusses the take-home messages from data for combination therapy for CLL presented at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.
Shared By : VJHemOnc
Posted on : 02/05/18
Added : 10 months ago